Mas-ComaSJonesMKMartyAM. COVID-19 and globalization. One Health2020; 9: 100132.
2.
AndersenKGRambautALipkinWI, et al. The proximal origin of SARS-CoV-2. Nat Med2020; 26(4): 450–452.
3.
PerlmanS. Another decade, another coronavirus. N Engl J Med2020; 382(8): 760–762.
4.
PeeriNCShresthaNRahmanMS, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: What lessons have we learned?Int J Epidemiol. Epub ahead of print 22 February 2020. DOI: 10.1093/ije/dyaa033.
5.
Soelberg SorensenP. Safety concerns and risk management of multiple sclerosis therapies. Acta Neurol Scand2017; 136(3): 168–186.
6.
BlockVJBoveRZhaoC, et al. Association of continuous assessment of step count by remote monitoring with disability progression among adults with multiple sclerosis. JAMA Netw Open2019; 2(3): e190570.
7.
MarrieRALeungSTyryT, et al. Use of eHealth and mHealth technology by persons with multiple sclerosis. Mult Scler Relat Disord2019; 27: 13–19.
8.
MarziniakMBrichettoGFeysP, et al. The use of digital and remote communication technologies as a tool for multiple sclerosis management: Narrative review. Rehabil Assist Technol2018; 5(1): e5.
9.
HoustonFAndréolettiO. Animal prion diseases: The risks to human health. Brain Pathol2019; 29(2): 248–262.
10.
EatonLAKalichmanSC. Social and behavioral health responses to COVID-19: Lessons learned from four decades of an HIVpandemic. J Behav Med2020; 43(3): 341–345.
